It may induce Nrf2 dissociation, increase the expression of phase II enzymes such as HO-1, GSTs and NQO1 by combining with nucleophiles (such as Keap1) in cells and can be used to treat pulmonary fibrosis (Divya et al., 2016). Here, NFE2L2 is linked to pulmonary fibrosis.